3116 Introduction: Prostate-specific membrane antigen-PSMA (also known as glutamate
carboxypeptidase II) is overexpressed in prostate cancer epithelium, making it a target for …

Objective To evaluate the feasibility of using 68 Ga PSMA-11 PET/CT for imaging brain
lesions and its comparison with 18 F-FDG. Methods Ten patients with brain lesions were …

Background Gliomas are the most common primary central nervous system tumors, of which
the malignant gliomas account for 60%–75%. The primary and secondary brain …

Glutamate carboxypeptidase II (GCP), also known as prostate specific membrane antigen
(PSMA) has been found to be expressed in glioma vasculature in in-vitro studies. GCP …

Background: Radiolabeled prostate-specific membrane antigen PSMA-based PET/CT or
PET/MRI is a whole-body imaging technique currently performed for the detection of prostate …

A 75-year-old man with a 6-year history of left auditory neuroma was referred for a follow up
MRI scan. The MRI scan revealed a known stable neuroma and a 42× 42× 58 mm abnormal …

Abstract 18 F-PSMA PET/CT is an emerging standard of care in staging prostate cancer,
evaluating biochemical recurrence and response to therapy. Despite the nomenclature …

Background Imaging of gliomas remains challenging. The aim of the study was to assess the
feasibility of using 68 Ga-PSMA-11 PET/CT for imaging gliomas. Methods Fifteen patients …

146 Purpose: PSMA is prostate-specific membrane antigen and abnormally expressed in
prostate cancer, subtypes of transitional cell carcinoma, renal cell carcinoma, colon …

590 Objectives: 68 Ga-PSMA-11 (prostate-specific membrane antigen) PET/CT has recently
showed significant impact in the management of prostate cancer (PCa). The main …